Found: 37
Select item for more details and to access through your institution.
Network Pharmacology and Molecular Docking Analysis of Shufeiya Recipe in the Treatment of Pulmonary Hypertension.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/7864976
- By:
- Publication type:
- Article
Pulmonary Vascular Remodeling in Pulmonary Hypertension.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 2, p. 366, doi. 10.3390/jpm13020366
- By:
- Publication type:
- Article
Traditional chinese medicine in coronary microvascular disease.
- Published in:
- Frontiers in Pharmacology, 2022, v. 10, p. 1, doi. 10.3389/fphar.2022.929159
- By:
- Publication type:
- Article
TanshinoneIIA Alleviates Inflammatory Response and Directs Macrophage Polarization in Lipopolysaccharide-Stimulated RAW264.7 Cells.
- Published in:
- Inflammation, 2019, v. 42, n. 1, p. 264, doi. 10.1007/s10753-018-0891-7
- By:
- Publication type:
- Article
Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Anomalous origin of the left coronary artery from the pulmonary artery: A rare case in an adult.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2024, v. 82, n. 7/8, p. 800, doi. 10.33963/v.phj.100916
- By:
- Publication type:
- Article
Shufeiya Recipe Improves Monocrotaline-Induced Pulmonary Hypertension in Rats by Regulating SIRT3/FOXO3a and Its Downstream Signaling Pathways.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/3229888
- By:
- Publication type:
- Article
Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.659707
- By:
- Publication type:
- Article
Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE<sup>−/−</sup> Mice.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.610550
- By:
- Publication type:
- Article
Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144387
- By:
- Publication type:
- Article
Investigation of the Cellular Pharmacological Mechanism and Clinical Evidence of the Multi-Herbal Antiarrhythmic Chinese Medicine Xin Su Ning.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00600
- By:
- Publication type:
- Article
Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms.
- Published in:
- International Journal of Medical Sciences, 2023, v. 20, n. 8, p. 1024, doi. 10.7150/ijms.85789
- By:
- Publication type:
- Article
M2 Macrophage‐Derived sEV Regulate Pro‐Inflammatory CCR2<sup>+</sup> Macrophage Subpopulations to Favor Post‐AMI Cardiac Repair.
- Published in:
- Advanced Science, 2023, v. 10, n. 14, p. 1, doi. 10.1002/advs.202202964
- By:
- Publication type:
- Article
Optimized new Shengmai powder ( 优化新生脉散方) inhibits myocardial fibrosis in heart failure by regulating the rat sarcoma/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular regulated protein kinases signaling pathway.
- Published in:
- Journal of Traditional Chinese Medicine, 2024, v. 44, n. 3, p. 448, doi. 10.19852/j.cnki.jtcm.20240402.004
- By:
- Publication type:
- Article
Protocol to study the effects of Traditional Chinese Medicine on patients with coronary heart disease showing phlegm-heat-stasis symptom pattern.
- Published in:
- Journal of Traditional Chinese Medicine, 2021, v. 41, n. 5, p. 826, doi. 10.19852/j.cnki.jtcm.2021.05.016
- By:
- Publication type:
- Article
Western medication plus Traditional Chinese Medicine preparations in patients with chronic heart failure: a prospective, single-blind, randomized, controlled, and multicenter clinical trial.
- Published in:
- Journal of Traditional Chinese Medicine, 2017, v. 37, n. 6, p. 756, doi. 10.1016/s0254-6272(18)30038-4
- By:
- Publication type:
- Article
Qi Dan Li Xin pill improves chronic heart failure by regulating mTOR/p70S6k-mediated autophagy and inhibiting apoptosis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63090-9
- By:
- Publication type:
- Article
Efficacy and Safety of Yangyin Shuxin Decoction—a Chinese Herbal Medicine Formula For Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2022, p. 1, doi. 10.1155/2022/1486366
- By:
- Publication type:
- Article
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome).
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2019, p. 1, doi. 10.1155/2019/9297163
- By:
- Publication type:
- Article
Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 6, p. 3881, doi. 10.1002/ehf2.12980
- By:
- Publication type:
- Article
Rg3 regulates myocardial pyruvate metabolism via P300-mediated dihydrolipoamide dehydrogenase 2-hydroxyisobutyrylation in TAC-induced cardiac hypertrophy.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 12, p. 1, doi. 10.1038/s41419-022-05516-y
- By:
- Publication type:
- Article
Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure.
- Published in:
- Chinese Medicine, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13020-024-00902-4
- By:
- Publication type:
- Article
Validation of evidence-based questionnaire for TCM syndrome differentiation of heart failure and evaluation of expert consensus.
- Published in:
- Chinese Medicine, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13020-023-00757-1
- By:
- Publication type:
- Article
Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
- Published in:
- Trials, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s13063-015-0729-7
- By:
- Publication type:
- Article
Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Study on the evaluation of the clinical effects of traditional chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
- Published in:
- Cardiovascular Drugs & Therapy, 2018, v. 32, n. 3, p. 295, doi. 10.1007/s10557-018-6791-0
- By:
- Publication type:
- Article
Ferroptosis: The Potential Target in Heart Failure with Preserved Ejection Fraction.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 18, p. N.PAG, doi. 10.3390/cells11182842
- By:
- Publication type:
- Article
Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1171119
- By:
- Publication type:
- Article
Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1154167
- By:
- Publication type:
- Article
Entropy-driven reactions for controlling CRISPR/Cas12a and constructing an electrochemical biosensor for cardiac biomarkers detection.
- Published in:
- Microchimica Acta, 2023, v. 190, n. 11, p. 1, doi. 10.1007/s00604-023-06012-6
- By:
- Publication type:
- Article
Additional traditional Chinese medicine on gastrointestinal dysfunction in patients with sepsis: A systematic review and meta-analysis.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2016, v. 29, p. 663
- By:
- Publication type:
- Article
Biomarkers in heart failure: the past, current and future.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Regulation mechanism of microRNAs in cardiac cells-derived exosomes in cell crosstalk.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1399850
- By:
- Publication type:
- Article
A Powerful Tool in the Treatment of Myocardial Ischemia-Reperfusion Injury: Natural and Nanoscale Modified Small Extracellular Vesicles Derived from Mesenchymal Stem Cells.
- Published in:
- International Journal of Nanomedicine, 2023, v. 18, p. 8099, doi. 10.2147/IJN.S443716
- By:
- Publication type:
- Article
Cavum septum pellucidum and first-episode psychosis: A meta-analysis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177715
- By:
- Publication type:
- Article